Time Lag of Acromegaly Diagnosis and Associated Comorbidities in Sulaymaniyah City/Iraq
Keywords:
Acromegaly, Colonoscopy findings, Comorbidity burden , Diagnosis delayAbstract
Background: Acromegaly is a rare endocrine disease. The insidious onset and symptom overlap with frequently found diseases, resulting in an often delayed diagnosis. Objective: To evaluate diagnostic delay in patients with acromegaly and its association with patient findings in Sulaymaniyah, Iraq. Methods: A retrospective cross-sectional study was conducted in 49 patients diagnosed with acromegaly. Patient data were collected through interviews and medical record review. The diagnostic delay was determined as the period between the onset of symptoms and the formal diagnosis. Results: The average diagnostic delay was 3.3 years, and the majority of patients were diagnosed with five years of symptom onset. Hypertension was observed in 32.7% of patients, and unemployment, lower education, cumulative comorbidity burden, and abnormal colonoscopy findings were significantly associated with longer delays. In patients <40 years old, the delay can be more extreme, wherein close to half had not undergone a colonoscopy. Normal finding (34.6%), polyps (15.4%), and malignancy (3.8%). However, in patients aged ≥40 years (46.9%), all underwent colonoscopy; 65.2% were normal, 26.1% had polyps, and 8.7% had malignancy. Overall, colorectal cancer was detected in three patients (6.1%), and there was a statistically significant correlation between age group and colonoscopic findings. Conclusions: Acromegaly diagnostic delay is substantial in the Kurdistan Region and is related to socioeconomic factors, asymptomatic onset, and comorbidity. Increased awareness, access to endocrinology, and broader colorectal screening are essential to improve outcomes.
Downloads
References
Wang K, Guo X, Yu S, Gao L, Wang Z, Zhu H, et al. Patient-identified problems and influences associated with diagnostic delay of acromegaly: A nationwide cross-sectional study. Front Endocrinol. 2021;12:704496. doi: 10.3389/fendo.2021.704496.
Melmed S. Pituitary tumors. Endocrinol Metab Clin North Am. 2015;44(1):1-9. doi: 10.1016/j.ecl.2014.11.004.
Liu X, Wang R, Li M, Chen G. Pituitary adenoma or pituitary neuroendocrine tumor: A narrative review of controversy and perspective. Transl Cancer Res. 2021;10(4):1916-1920. doi: 10.21037/tcr-20-3446.
Bianchi A, Chiloiro S, Giampietro A, Gaudino S, Calandrelli R, Mazzarella C, et al. Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors. Front Endocrinol. 2023;14:1123267. doi: 10.3389/fendo.2023.1123267.
Zendran I, Gut G, Kaluzny M, Zawadzka K, Bolanowski M. Acromegaly caused by ectopic growth hormone releasing hormone secretion: A review. Front Endocrinol (Lausanne). 2022;13:867965. doi: 10.3389/fendo.2022.867965.
Lenders NF, Earls PE, Inder WJ, Mccormack AI. The evolution in pituitary tumour classification: A clinical perspective. Endocr Oncol. 2023;3(1):e220079. doi: 10.1530/EO-22-0079.
Ravindra VM, Raheja A, Corn H, Driscoll M, Welt C, Simmons DL, et al. Primary pituitary diffuse large b-cell lymphoma with somatotroph hyperplasia and acromegaly: Case report. J Neurosurg. 2017;126(5):1725-1730. doi: 10.3171/2016.5.JNS16828.
Dhaneshwar S, Shandily S, Tiwari V. Growth hormone excess: Implications and management. Endocr. Metab. Immune Disord. Drug Targets. 2023;23(6):748-763. doi: 10.2174/1871530322666221012155533.
Elbaum M, Daroszewski J, Bolanowski M. Cardiovascular complications of acromegaly. Acta Endocrinol (Buchar.). 2018;14(3):365. doi: 10.4183/aeb.2018.365.
Rivera FB, Taliño MK, Ansay MF, Mangubat GF, Mahilum ML, Menghrajani RH, et al. Cardiovascular effects of excess growth hormone: How real is the threat? Rev Cardiovasc Med. 2023;24(4):95. doi: 10.31083/j.rcm2404095.
Dal J, Leisner MZ, Hermansen K, Farkas DK, Bengtsen M, Kistorp C, et al. Cancer incidence in patients with acromegaly: A cohort study and meta-analysis of the literature. J Clin Endocrinol Metab. 2018;103(6):2182-2188. doi: 10.1210/jc.2017-02457.
Hannon AM, Thompson CJ, Sherlock M. Diabetes in patients with acromegaly. Curr Diab Rep. 2017;17(2):8. doi: 10.1007/s11892-017-0838-7.
Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, et al. A consensus on the diagnosis and treatment of acromegaly comorbidities: An update. J Clin Endocrinol Metab. 2020;105(4). doi: 10.1210/clinem/dgz096.
Algahtany M, Sharma S, Fahoum K, Jing R, Zhang S, Kovacs K, et al. The role of growth hormone in depression: A human model. Front Neurosci. 2021;15:661819. doi: 10.3389/fnins.2021.661819.
Zahr R, Fleseriu M. Updates in diagnosis and treatment of acromegaly. Eur Endocrinol. 2018;14(2):57-61. doi: 10.17925/EE.2018.14.2.57.
Chiloiro S, Giampietro A, Gagliardi I, Bondanelli M, Veleno M, Ambrosio MR, et al. Impact of the diagnostic delay of acromegaly on bone health: Data from a real life and long term follow-up experience. Pituitary. 2022;25(6):831-841. doi: 10.1007/s11102-022-01266-4.
Carroll PV, Joshi MN. Acromegaly. 2022 Sep 7. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, et al, (editors). Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. PMID: 25905322.
Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S. Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 2022;10(11):804-826. doi: 10.1016/S2213-8587(22)00244-3.
Bai X, Duan L, Yang S, Wang T, Yao Y, Zhang M, et al. Biochemical remission, diagnostic delays, and comorbidities of acromegaly in china: A large single-centre retrospective study. Front Endocrinol (Lausanne). 2025;16:1526625. doi: 10.3389/fendo.2025.1526625.
Esposito D, Ragnarsson O, Johannsson G, Olsson DS. Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol. 2020;182(6):523-531. doi: 10.1530/EJE-20-0019.
Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest. 2009;119(11):3189-3202. doi: 10.1172/JCI39375.
Colao A, Grasso LF, Giustina A, Melmed S, Chanson P, Pereira AM, et al. Acromegaly. Nat Rev. Dis Primers. 2019;5(1):20. doi: 10.1038/s41572-019-0081-7.
Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary. 1999;2:29-41. doi: 10.1023/a:1009965803750.
Chanson P, Salenave S. Acromegaly. Orphanet J Rare Dis. 2008;3(1):17. doi: 10.1186/1750-1172-3-17.
Ben-Shlomo A, Melmed S. Acromegaly. Endocrinol Metab Clin North Am. 2008;37(1):101-122. doi: 10.1016/j.ecl.2007.10.002.
Adelman DT, Liebert KJ, Nachtigall LB, Lamerson M, Bakker B. Acromegaly: The disease, its impact on patients, and managing the burden of long-term treatment. Int J Gen Med. 2013;6:31-38. doi: 10.2147/IJGM.S38594.
Almalki MH, Elhadd T, Aldahmani KM, Ekhzaimy A, Alqanaei A, Frookh H, et al. Management of patients with acromegaly in clinical practice in the gulf countries: A delphi consensus survey. Front Endocrinol. 2025;16:1593959. doi: 10.3389/fendo.2025.1593959.
Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Mortality in acromegaly: A metaanalysis. J Clin Endocrinol Metab. 2008;93(1):61-67. doi: 10.1210/jc.2007-1191.
Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933-3951. doi: 10.1210/jc.2014-2700.
Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, et al. Multidisciplinary management of acromegaly: A consensus. Rev Endocr Metab Disord. 2020;21(4):667-678. doi: 10.1007/s11154-020-09588-z.
Renehan AG, O'connell J, O'halloran D, Shanahan F, Potten CS, O'dwyer ST, et al. Acromegaly and colorectal cancer: A comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res. 2003;35(11-12):712-725. doi: 10.1055/s-2004-814150.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Published by Al-Rafidain University College. This is an open access journal issued under the CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).



